Hone Bio

Private

Last Round

Series A

Mar 16, 2021

Total Funding Raised

$6.5M

Company Overview

Hone Bio is a biotechnology company developing a lipid nanoparticle (LNP) targeting technology for enhanced drug delivery.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Mar 16, 2021
Seed	Nov 25, 2019

Notable investors and investment history

Investor	Rounds
Bristol Private Equity Club	Series A, Seed
Meltwind Advisory	Series A
University of Bristol Enterprise Fund	Series A, Seed
Science Creates Ventures	Series A
Luminous Ventures	Series A
Outsized Ventures	Series A
UK Innovation & Science Seed Fund	Series A, Seed

Structured signals derived from secondary market and firmographic data.

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about Hone Bio's valuation, stock price, and market status.

HeadquartersBristol

Employee Range-

Year Founded2017

Last FundingMar 16, 2021

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.